Literature DB >> 18270793

Optimizing management of metabolic syndrome to reduce risk: focus on life-style.

Cristina Bianchi1, Giuseppe Penno, Giuseppe Daniele, Luca Benzi, Stefano Del Prato, Roberto Miccoli.   

Abstract

The prevalence of metabolic syndrome (MS) is increasing all over the world and its incidence is expected to rise in the next years. Although genetic predisposition appears to play an important role in the regulation of metabolic parameters and in particular of body weight, the rapid increase in the prevalence of obesity and MS suggests that ecological factors (social, economic, cultural and physical environment) are promoting those conditions in susceptible individuals. People with MS are at increased risk of type 2 diabetes and cardiovascular disease and therefore they represent a priority target for preventive strategies. Life-style modifications based on healthy diet and increased physical activity are an effective preventing and therapeutic approach. Unfortunately, implementation of life-style modification and maintenance of effects is a difficult task both at personal and social level, thus drug therapy can be taken into account.

Entities:  

Mesh:

Year:  2008        PMID: 18270793     DOI: 10.1007/s11739-008-0122-6

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  138 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

2.  Trends in food locations and sources among adolescents and young adults.

Authors:  Samara Joy Nielsen; Anna Maria Siega-Riz; Barry M Popkin
Journal:  Prev Med       Date:  2002-08       Impact factor: 4.018

Review 3.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

4.  The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

Authors:  Trevor J Orchard; Marinella Temprosa; Ronald Goldberg; Steven Haffner; Robert Ratner; Santica Marcovina; Sarah Fowler
Journal:  Ann Intern Med       Date:  2005-04-19       Impact factor: 25.391

5.  Effects of the amount and intensity of exercise on plasma lipoproteins.

Authors:  William E Kraus; Joseph A Houmard; Brian D Duscha; Kenneth J Knetzger; Michelle B Wharton; Jennifer S McCartney; Connie W Bales; Sarah Henes; Gregory P Samsa; James D Otvos; Krishnaji R Kulkarni; Cris A Slentz
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

6.  Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study.

Authors:  X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

Review 7.  Fat and sugar: an economic analysis.

Authors:  Adam Drewnowski
Journal:  J Nutr       Date:  2003-03       Impact factor: 4.798

8.  The effect of endurance exercise training on plasma lipoprotein AI and lipoprotein AI:AII concentrations in sedentary adults.

Authors:  Kenneth R Wilund; Perry L Colvin; Dana Phares; Andrew P Goldberg; James M Hagberg
Journal:  Metabolism       Date:  2002-08       Impact factor: 8.694

9.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.

Authors:  David E Laaksonen; Hanna-Maaria Lakka; Leo K Niskanen; George A Kaplan; Jukka T Salonen; Timo A Lakka
Journal:  Am J Epidemiol       Date:  2002-12-01       Impact factor: 4.897

Review 10.  Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review.

Authors:  A Poobalan; L Aucott; W C S Smith; A Avenell; R Jung; J Broom; A M Grant
Journal:  Obes Rev       Date:  2004-02       Impact factor: 9.213

View more
  5 in total

1.  Weight loss in individuals with metabolic syndrome given DASH diet counseling when provided a low sodium vegetable juice: a randomized controlled trial.

Authors:  Sonia F Shenoy; Walker Sc Poston; Rebecca S Reeves; Alexandra G Kazaks; Roberta R Holt; Carl L Keen; Hsin Ju Chen; C Keith Haddock; Barbara L Winters; Chor San H Khoo; John P Foreyt
Journal:  Nutr J       Date:  2010-02-23       Impact factor: 3.271

2.  Sugar-Sweetened Beverage Consumption Is Associated with Metabolic Syndrome in Iranian Adults: Tehran Lipid and Glucose Study.

Authors:  Hanieh Sadat Ejtahed; Zahra Bahadoran; Parvin Mirmiran; Fereidoun Azizi
Journal:  Endocrinol Metab (Seoul)       Date:  2015-05-18

3.  Exploring the Experiences of Iranian Women Regarding Obesity Self-Management: A Qualitative Study.

Authors:  Omolhoda Kaveh; Hamid Peyrovi
Journal:  Open Access Maced J Med Sci       Date:  2019-07-29

4.  Development of a behavior change intervention to improve physical activity adherence in individuals with metabolic syndrome using the behavior change wheel.

Authors:  Dandan Chen; Hui Zhang; Nianqi Cui; Feng Song; Leiwen Tang; Jing Shao; Jingjie Wu; Pingping Guo; Na Liu; Xiyi Wang; Zhihong Ye
Journal:  BMC Public Health       Date:  2022-09-14       Impact factor: 4.135

5.  Empirical dietary inflammatory pattern and risk of metabolic syndrome and its components: Tehran Lipid and Glucose Study.

Authors:  Zeinab Shakeri; Parvin Mirmiran; Sajjad Khalili-Moghadam; Firoozeh Hosseini-Esfahani; Asal Ataie-Jafari; Fereidoun Azizi
Journal:  Diabetol Metab Syndr       Date:  2019-02-12       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.